UBCS039

UBCS039
	File:UBCS039 structure.png
临床资料
药物类别	Sirtuin-6 (SIRT6) activator
识别信息
	IUPAC命名法 4-pyridin-3-yl-4,5-dihydropyrrolo[1,2-a]quinoxaline; ;
CAS号	358721-70-7
PubChem CID	2803797;
E编码	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Module:EditAtWikidata第29行Lua错误：attempt to index field 'wikibase' (a nil value);
ECHA InfoCard	{{#property:P2566}}Module:EditAtWikidata第29行Lua错误：attempt to index field 'wikibase' (a nil value)
化学信息
化学式	C16H13N3
摩尔质量	247.30 g·mol−1
3D模型（JSmol）	交互式图像;
	SMILES C1=CC=C2C(=C1)NC(C3=CC=CN32)C4=CN=CC=C4;
	InChI InChI=1S/C16H13N3/c1-2-7-14-13(6-1)18-16(12-5-3-9-17-11-12)15-8-4-10-19(14)15/h1-11,16,18H; Key:BSOBGTYXYGHUTD-UHFFFAOYSA-N;

参考文献[编辑]

^ Wang D, Zhou Y, Yang N, Liu J, Lu L, Gao Z. SIRT6 mitigates acute kidney injury by enhancing lipid metabolism and reducing tubular epithelial cell apoptosis via suppression of the ACMSD signaling pathway. Cellular Signalling. July 2025, 131. PMID 40120964. doi:10.1016/j.cellsig.2025.111757. 已忽略未知参数|article-number= (帮助)
^ Sinha R, Singh P, Zeng H, Kumar A, Antony VB. Cadmium exposure triggers vimentin phosphorylation via SIRT6-regulated AKT/PI3K signaling pathway in COPD. European Journal of Cell Biology. September 2025, 104 (3). PMID 40609497. doi:10.1016/j.ejcb.2025.151503. 已忽略未知参数|article-number= (帮助)